DCK and hyperinsulinemic hypoglycemia, familial, 4: The phosphodiester derivative of cytarabine UA911 has been able to circumvent DCK deficiency [246] while another pronucleotide, cytarabine phosphoramidate, has demonstrated better activity on hENT1- and DCK-deficient cells than cytarabine [247].